Literature DB >> 16741254

Reversible inhibition of the platelet procoagulant response through manipulation of the Gardos channel.

Jef L Wolfs1, Simone J Wielders, Paul Comfurius, Theo Lindhout, John C Giddings, Robert F Zwaal, Edouard M Bevers.   

Abstract

The platelet procoagulant response requires a sustained elevation of the intracellular Ca2+ concentration, [Ca2+]i, causing exposure of phosphatidylserine (PS) at the outer surface of the plasma membrane. An increased [Ca2+]i also activates Ca2+-dependent K+ channels. Here, we investigated the contribution of the efflux of K+ ions on the platelet procoagulant response in collagen-thrombin-activated platelets using selective K+ channel blockers. The Gardos channel blockers clotrimazol, charybdotoxin, and quinine caused a similar decrease in prothrombinase activity as well as in the number of PS-exposing platelets detected by fluorescence-conjugated annexin A5. Apamin and iberiotoxin, inhibitors of other K+ channels, were without effect. Only clotrimazol showed a significant inhibition of the collagen-plus-thrombin-induced intracellular calcium response. Clotrimazol and charybdotoxin did not inhibit aggregation and release under the conditions used. Inhibition by Gardos channel blockers was reversed by valinomycin, a selective K+ ionophore. The impaired procoagulant response of platelets from a patient with Scott syndrome was partially restored by pretreatment with valinomycin, suggesting a possible defect of the Gardos channel in this syndrome. Collectively, these results provide evidence for the involvement of efflux of K+ ions through Ca2+-activated K+ channels in the procoagulant response of platelets, opening potential strategies for therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741254     DOI: 10.1182/blood-2006-01-009613

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  2-Aminoethoxydiphenylborate (2-APB) inhibits release of phosphatidylserine-exposing extracellular vesicles from platelets.

Authors:  Hao Wei; Jessica E Davies; Matthew T Harper
Journal:  Cell Death Discov       Date:  2020-03-02

2.  Therapeutic potential of KCa3.1 blockers: recent advances and promising trends.

Authors:  Heike Wulff; Neil A Castle
Journal:  Expert Rev Clin Pharmacol       Date:  2010-05       Impact factor: 5.045

Review 3.  Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis.

Authors:  Olivier Morel; Nicolas Morel; Laurence Jesel; Jean-Marie Freyssinet; Florence Toti
Journal:  Semin Immunopathol       Date:  2011-08-25       Impact factor: 9.623

4.  Critical role for CD38-mediated Ca2+ signaling in thrombin-induced procoagulant activity of mouse platelets and hemostasis.

Authors:  Mazhar Mushtaq; Tae-Sik Nam; Uh-Hyun Kim
Journal:  J Biol Chem       Date:  2011-02-21       Impact factor: 5.157

5.  Mitochondrial calcium and reactive oxygen species regulate agonist-initiated platelet phosphatidylserine exposure.

Authors:  Hyo-Jung Choo; Talib B Saafir; Laura Mkumba; Mary B Wagner; Shawn M Jobe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10-18       Impact factor: 8.311

6.  Exenatide Inhibits the KCa3.1 Channels of Aortic Vascular Smooth Muscle in Diabetic Rats.

Authors:  Peng Dong; Minglong Liu; Chaofeng Liu
Journal:  Acta Cardiol Sin       Date:  2017-11       Impact factor: 2.672

Review 7.  Diabetes Mellitus and Ischemic Heart Disease: The Role of Ion Channels.

Authors:  Paolo Severino; Andrea D'Amato; Lucrezia Netti; Mariateresa Pucci; Marialaura De Marchis; Raffaele Palmirotta; Maurizio Volterrani; Massimo Mancone; Francesco Fedele
Journal:  Int J Mol Sci       Date:  2018-03-10       Impact factor: 5.923

8.  Colchicine inhibits ROS generation in response to glycoprotein VI stimulation.

Authors:  G J Pennings; C J Reddel; M Traini; H Campbell; V Chen; L Kritharides
Journal:  Sci Rep       Date:  2021-06-07       Impact factor: 4.379

9.  Scorpion peptides: potential use for new drug development.

Authors:  Bennasr Hmed; Hammami Turky Serria; Zeghal Khaled Mounir
Journal:  J Toxicol       Date:  2013-06-15

10.  2-Aminoethoxydiphenylborate (2-APB) inhibits release of phosphatidylserine-exposing extracellular vesicles from platelets.

Authors:  Hao Wei; Jessica E Davies; Matthew T Harper
Journal:  Cell Death Discov       Date:  2020-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.